In light of the recent news on the Oxford Covid-19 vaccine, John Rountree, was invited on CNBC to discuss the outlook.
Discover John’s previous comments on the vaccine here.
Media
Oxford vaccine news is very encouraging (CNBC)
In light of the recent news on the Oxford Covid-19 vaccine, John Rountree, was invited on CNBC to discuss the outlook.
Discover John’s previous comments on the vaccine here.
Related
Media
Sandoz will be a long-term stable business if it can get its cost structure right (CNBC)
DiscoverPharma/Biotech R&D Effectiveness: What it Takes – Exclusive Workshop
DiscoverHow European MidPharmas have grown profits (MedNous)
Discover